What is Joy Therapeutics?
Joy Therapeutics is a specialized provider of pediatric therapy services, focusing on Applied Behavior Analysis (ABA), child development psychology, and DIR Floortime. Founded by Dvora Phillip, the company champions a child-centered methodology to address a spectrum of developmental challenges, including emotional, behavioral, sensory, social, and communication issues. Operating from a state-of-the-art clinic and offering in-home services, Joy Therapeutics also emphasizes parent training to foster stronger parent-child dynamics. The company's core objective is to effect significant positive changes in children's lives through precisely tailored therapeutic interventions.
How much funding has Joy Therapeutics raised?
Joy Therapeutics has raised a total of $18K across 1 funding round:
Debt
$18K
Debt (2021): $18K with participation from PPP
Key Investors in Joy Therapeutics
PPP
Public-Private Partnership
What's next for Joy Therapeutics?
Operating at a Series A/B growth stage, Joy Therapeutics' recent capital injection is poised to accelerate its expansion and enhance its service offerings. The strategic investment will likely fuel advancements in clinic infrastructure, therapeutic program development, and potentially broaden its geographic reach. This infusion of financing signals strong investor confidence in Joy Therapeutics' model and its capacity to scale its impact within the pediatric therapy sector, aiming for sustained growth and deeper community penetration.
See full Joy Therapeutics company page
